Covered recipient · General Payments record
AMY WOLFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$2,563.15
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $814.29 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $345.49 | 26 |
| BOSTON SCIENTIFIC CORPORATION | $146.12 | 1 |
| Novo Nordisk AS | $112.84 | 1 |
| CVRx Inc. | $96.02 | 2 |
| Acerta Pharma LLC | $34.34 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.03 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $30.29 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $10.27 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212918 | CMS |
| Amgen Inc. | $17.85 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212923 | CMS |
| Amgen Inc. | $8.93 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212930 | CMS |
| Amgen Inc. | $14.74 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212927 | CMS |
| Amgen Inc. | $7.44 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212935 | CMS |
| Amgen Inc. | $11.79 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212940 | CMS |
| Amgen Inc. | $9.24 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212890 | CMS |
| Amgen Inc. | $11.06 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720916 | CMS |
| Amgen Inc. | $17.39 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212895 | CMS |
| Amgen Inc. | $9.50 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212899 | CMS |
| Amgen Inc. | $10.83 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212903 | CMS |
| Amgen Inc. | $19.71 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212907 | CMS |
| Amgen Inc. | $18.91 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212910 | CMS |
| Amgen Inc. | $15.99 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212915 | CMS |
| Amgen Inc. | $15.44 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212953 | CMS |
| Amgen Inc. | $15.99 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212957 | CMS |
| Amgen Inc. | $10.35 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212961 | CMS |
| Amgen Inc. | $15.64 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212965 | CMS |
| Amgen Inc. | $16.74 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212969 | CMS |
| Amgen Inc. | $14.50 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720918 | CMS |
| Amgen Inc. | $10.54 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720920 | CMS |
| Amgen Inc. | $14.00 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720922 | CMS |
| Amgen Inc. | $7.62 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212944 | CMS |
| Amgen Inc. | $10.39 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720924 | CMS |
| Amgen Inc. | $12.66 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117720926 | CMS |
| Amgen Inc. | $17.97 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212949 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.49 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104451474 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104339132 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.40 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086327745 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.89 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086341265 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.39 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118014938 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.64 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118014936 | CMS |
| Boston Scientific Corporation | $146.12 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474339 | CMS |
| CVRx, Inc. | $74.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140963076 | CMS |
| CVRx, Inc. | $22.02 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140963078 | CMS |
| Novartis Pharmaceuticals Corporation | $15.16 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087424998 | CMS |
| Novo Nordisk Inc | $112.84 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100518475 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.